Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE0.9373
- TODAY'S CHANGE (%)0.0465 (5.2200%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.8839 / 0.8908
- Day Range
- 52 Week Range
- Volume118,069
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 6190 | 0.8839 |
| 09:39 ET | 1036 | 0.8885 |
| 09:42 ET | 593 | 0.8802 |
| 09:44 ET | 200 | 0.8968 |
| 09:46 ET | 500 | 0.8968 |
| 09:48 ET | 100 | 0.8805 |
| 09:50 ET | 281 | 0.8887 |
| 09:53 ET | 6033 | 0.86 |
| 09:55 ET | 3488 | 0.8648 |
| 09:57 ET | 12389 | 0.86 |
| 10:00 ET | 100 | 0.853 |
| 10:02 ET | 1450 | 0.854901 |
| 10:04 ET | 400 | 0.8654 |
| 10:06 ET | 1071 | 0.87 |
| 10:11 ET | 500 | 0.87575 |
| 10:13 ET | 250 | 0.880373 |
| 10:15 ET | 2150 | 0.8795 |
| 10:22 ET | 2200 | 0.870442 |
| 10:24 ET | 9389 | 0.8733 |
| 10:26 ET | 223 | 0.877 |
| 10:27 ET | 7004 | 0.8804 |
| 10:36 ET | 100 | 0.88835 |
| 10:42 ET | 268 | 0.888349 |
| 10:44 ET | 800 | 0.8996 |
| 10:49 ET | 7489 | 0.8899 |
| 10:51 ET | 200 | 0.89505 |
| 11:02 ET | 2101 | 0.89765 |
| 11:03 ET | 1000 | 0.9 |
| 11:09 ET | 100 | 0.897 |
| 11:18 ET | 100 | 0.897 |
| 11:20 ET | 900 | 0.8969 |
| 11:25 ET | 3500 | 0.897 |
| 11:30 ET | 400 | 0.8975 |
| 11:38 ET | 1400 | 0.897939 |
| 11:41 ET | 421 | 0.8978 |
| 11:45 ET | 200 | 0.9 |
| 11:54 ET | 1955 | 0.897 |
| 11:57 ET | 200 | 0.891853 |
| 12:06 ET | 100 | 0.91 |
| 12:08 ET | 100 | 0.91 |
| 12:12 ET | 100 | 0.91 |
| 12:21 ET | 100 | 0.91 |
| 12:33 ET | 100 | 0.91 |
| 12:46 ET | 1200 | 0.91 |
| 12:50 ET | 700 | 0.9125 |
| 12:55 ET | 196 | 0.9126 |
| 01:15 ET | 100 | 0.91 |
| 01:24 ET | 100 | 0.91 |
| 01:26 ET | 4144 | 0.91 |
| 01:29 ET | 100 | 0.9001 |
| 01:33 ET | 100 | 0.9105 |
| 01:38 ET | 146 | 0.91 |
| 01:44 ET | 632 | 0.90525 |
| 01:47 ET | 100 | 0.9105 |
| 01:54 ET | 2000 | 0.91 |
| 02:02 ET | 300 | 0.9105 |
| 02:12 ET | 100 | 0.9105 |
| 02:16 ET | 100 | 0.9105 |
| 02:20 ET | 552 | 0.9 |
| 02:25 ET | 100 | 0.90011 |
| 02:27 ET | 3000 | 0.9109 |
| 02:41 ET | 200 | 0.9055 |
| 02:43 ET | 100 | 0.9 |
| 02:52 ET | 200 | 0.911 |
| 02:59 ET | 100 | 0.9125 |
| 03:01 ET | 100 | 0.9125 |
| 03:10 ET | 1594 | 0.907798 |
| 03:14 ET | 100 | 0.9125 |
| 03:21 ET | 700 | 0.9124 |
| 03:26 ET | 1450 | 0.9125 |
| 03:28 ET | 1300 | 0.9241 |
| 03:35 ET | 100 | 0.9241 |
| 03:37 ET | 100 | 0.924 |
| 03:42 ET | 1250 | 0.9241 |
| 03:44 ET | 209 | 0.915001 |
| 03:46 ET | 1819 | 0.924 |
| 03:55 ET | 100 | 0.937 |
| 03:57 ET | 769 | 0.937 |
| 04:00 ET | 2926 | 0.9373 |
Nov 11, 2024
DJ Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co., from 6:55AM ET on Monday Nov 11, 2024 by Dow Jones
6:55AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones*DJ Co-Diagnostics 3Q Loss/Shr 32c >CODX, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in D sseldorf, Germany on Nov 11-14, 2024, from 9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 29.9M | -0.7x | --- |
T2 Biosystems Inc | 10.5M | -0.1x | --- |
Renalytix PLC | 28.4M | -0.3x | --- |
Medite Cancer Diagnostics Inc | 90.0 | 0.0x | --- |
Neuroone Medical Technologies Corp | 19.1M | -1.3x | --- |
Viveve Medical Inc | 4.3K | 0.0x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Dwight Egan
- President
- Richard Abbott
- Chief Financial Officer, Company Secretary
- Brian Brown
- Chief Operations Officer
- David Nielsen
- Chief Technology Officer
- Christopher Thurston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $29.9M |
|---|---|
Revenue (TTM) | $7.3M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.91 |
EPS | $-1.38 |
Book Value | $2.75 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -549.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
